Maria Gustafsson, a doctoral student and clinical pharmacist in the department of community medicine and rehabilitation at Umea University, carried out a randomized, controlled trial among 460 people from 65 years and above suffering from dementia and cognitive impairment.
Here are three points:
1. Before the study intervention was performed, researchers found as many as 41 percent of all admissions were related to medication events.
2. The most common problem was adverse drug reaction, but excessively high dosage and noncompliance was also unfortunately common.
3. The results after the intervention showed that clinical pharmacists’ participation in healthcare teams reduced the risk of drug-related hospital readmissions by half during the follow-up time of 180 days.
More articles on quality & infection control:
5 benefits of e-prescriptions
Ditching shorthand: Minnesota physicians offer clinical note access to patients
Congress to take $500M from Ebola budget; divert funds to combat Zika virus — 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
